LPCN logo

Lipocine (LPCN)

Profile

Full Name

Lipocine Inc.

Ticker Symbol

LPCN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 22, 2013

Indexes

Not included

Website

http://www.lipocine.com

Employees

16

Key Details

Price

$3.00(-0.33%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$11.20M(+492.81% YoY)

Annual EPS

$0.00(+100.00% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.00
LPCN price is $3.00

30-Day Relative Volume

0.35
LPCN 30-day relative volume is 0.35

Price Performance

Price Most recent change

-0.33%
LPCN price was down -0.33% on Apr 17, 2025

Price YTD change

-38.52%
LPCN price is down -38.52% since January 1st

Price 1-year change

-43.61%
LPCN price is down -43.61% year-on-year

Price 3-year change

-83.35%
LPCN price is down -83.35% over the past 3 years

Price Range

Price All-time high

$326.91
LPCN price is currently -99.08% below its historical high of $326.91

Price 3-year low

$2.31
LPCN price is currently +29.87% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$16.05M
LPCN market capitalization is $16.05 million

Market cap 3-year change

-82.89%
LPCN market capitalization is down -82.89% over the past 3 years

Market cap All-time high

$338.25M
LPCN market capitalization is currently -95.25% below its historical high of $338.25 million

Market cap sector rank

25.43%
LPCN market capitalization is higher than 25.43% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.05%
LPCN shares outstanding is up +0.05% year-on-year

Shares Outstanding 3-Year Change

+2.78%
LPCN shares outstanding is up +2.78% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
LPCN beta value is unknown

200-day SMA

$4.55
LPCN price is currently -34.13% below its 200-day simple moving average

50-day SMA

$3.30
LPCN price is currently -9.19% below its 50-day simple moving average

RSI

-
LPCN 14-day relative strength index value is unknown

Volume

0.35
LPCN 30-day relative volume is 0.35

ATR

-
LPCN average true range value is unknown

10-day Historical Volatility

-
LPCN 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$11.20M
LPCN annual revenue is $11.20 million

Revenue Analysts estimate

$1.50M
LPCN annual revenue is currently +644.55% higher than the consensus analysts' forecast

Revenue 1-year change

+492.81%
LPCN annual revenue is up +492.81% year-on-year

Revenue Sector rank

29.71%
LPCN annual revenue is higher than 29.71% of companies in Healthcare sector

EPS

EPS

$0.00
LPCN annual earnings per share is $0.00

EPS Analysts estimate

-
LPCN annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+100%
LPCN annual earnings per share is up +100% year-on-year

EPS Sector rank

82.1%
LPCN annual earnings per share is higher than 82.1% of companies in Healthcare sector

Profit

Gross profit

$3.85M
LPCN annual gross profit is $3.85 million

Gross margin

34.35%
LPCN annual gross profit margin is 34.35%

Operating profit

-$1.16M
LPCN annual operating income is -$1.16 million

Operating margin

-10.31%
LPCN annual operating profit margin is -10.31%

Net income

$8400.00
LPCN annual net profit is $8400.00

Net margin

0.07%
LPCN annual net profit margin is 0.07%

Expenses

Total expenses

$12.35M
LPCN annual total expenses is $12.35 million

Operating expenses

$5.00M
LPCN annual total operating expenses is $5.00 million

Cost of goods sold

$7.35M
LPCN annual cost of goods sold is $7.35 million

Selling, general & administrative expenses

$5.00M
LPCN annual SGA is $5.00 million

Depreciation and amortization

$41.10K
LPCN annual depreciation & amortization is $41.10 thousand

Interest expense

-
LPCN annual interest expense value is unknown

Income tax

$700.00
LPCN annual income tax is $700.00

EBIT & EBITDA

EBIT

-$1.16M
LPCN annual earnings before interest & taxes is -$1.16 million

EBITDA

-$1.11M
LPCN annual EBITDA is -$1.11 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$22.51M
LPCN annual total assets is $22.51 million

Non current assets

$188.80K
LPCN annual long term assets is $188.80 thousand

Current assets

$22.32M
LPCN annual total current assets is $22.32 million

Cash and cash equivalents

$6.21M
LPCN annual cash & cash equivalents is $6.21 million

Accounts receivable

-
LPCN annual accounts receivable value is unknown

Inventory

-
LPCN annual inventory value is unknown

Liabilities

Total liabilities

$1.51M
LPCN annual total liabilities is $1.51 million

Long term liabilities

$0.00
LPCN annual total long term liabilities is $0.00

Current liabilities

$1.51M
LPCN annual total current liabilities is $1.51 million

Accounts payable

$271.70K
LPCN annual accounts payable is $271.70 thousand

Debt

Total debt

$0.00
LPCN annual total debt is $0.00

Total debt 1-year change

0%
LPCN {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
LPCN annual long term debt value is unknown

Short term debt

-
LPCN annual short term debt value is unknown

Equity & Capital

Shareholders equity

$21.00M
LPCN annual stockholders equity is $21.00 million

Book value

$21.00M
LPCN annual book value is $21.00 million

Retained earnings

-$199.77M
LPCN annual retained earnings is -$199.77 million

Working capital

$20.81M
LPCN annual working capital is $20.81 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$1.22M
LPCN annual cash flow from operations is -$1.22 million

Cash from operations 1-year change

+89.71%
LPCN annual cash flow from operations is up +89.71% year-on-year

Cash from investing

$2.45M
LPCN annual cash flow from investing activities is $2.45 million

Cash from investing 1-year change

-81.31%
LPCN annual cash flow from investing activities is down -81.31% year-on-year

Cash from financing

$209.30K
LPCN annual cash flow from financing activities is $209.30 thousand

Cash from financing 1-year change

-48.27%
LPCN annual cash flow from financing activities is down -48.27% year-on-year

CAPEX

CAPEX

$90.10K
LPCN annual capital expenditures is $90.10 thousand

CAPEX 1-year change

+582.58%
LPCN annual capital expenditures is up +582.58% year-on-year

Free Cash Flow

Free cash flow

-$1.31M
LPCN annual free cash flow is -$1.31 million

Free cash flow 1-year change

+88.96%
LPCN annual free cash flow is up +88.96% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

34.35%
LPCN annual gross profit margin is 34.35%

Operating margin

-10.31%
LPCN annual operating profit margin is -10.31%

Net margin

0.07%
LPCN annual net profit margin is 0.07%

ROA & ROE

ROA

0.04%
LPCN annual return on assets is 0.04%

ROE

0.04%
LPCN annual return on equity is 0.04%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LPCN price to earnings ratio value is unknown

PE ratio Sector rank

-
LPCN price to earnings ratio is unknown

PB Ratio

PB ratio

0.76
LPCN price to book ratio is 0.76

PB ratio Sector rank

38.33%
LPCN price to book ratio is higher than 38.33% of companies in Healthcare sector

PS Ratio

PS ratio

1.43
LPCN price to sales ratio is 1.43

PS ratio Sector rank

34.92%
LPCN price to sales ratio is higher than 34.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.85M
LPCN enterprise value is $9.85 million

Enterprise value Sector rank

24.63%
LPCN enterprise value is higher than 24.63% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.84
LPCN EV/EBITDA is -8.84

EV/EBITDA Sector rank

11.92%
LPCN EV/EBITDA is higher than 11.92% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

14.75
LPCN annual current ratio is 14.75

Quick ratio

-
LPCN annual quick ratio value is unknown

Leverage

Debt to equity

0.00
LPCN annual debt to equity ratio is 0.00

Interest coverage ratio

-
LPCN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
LPCN piotroski f-score value is unknown

Altman Z-Score

-4.62
LPCN altman z-score is -4.62

Analyst ratings

Recent major analysts updates

Jul 27, 23 Cantor Fitzgerald
Overweight
Aug 26, 21 HC Wainwright & Co.
Buy
Jun 24, 21 Cantor Fitzgerald
Overweight
May 27, 21 HC Wainwright & Co.
Buy
Dec 10, 20 Ladenburg Thalmann
Buy
May 27, 20 HC Wainwright & Co.
Buy
Mar 29, 18 Seaport Global
Buy
Feb 27, 18 Empire Asset Management
Buy
Jan 11, 18 Canaccord Genuity
Hold
Oct 7, 16 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ALLR logo
Allarity Therapeutics (ALLR)
BCTX logo
BriaCell Therapeutics (BCTX)
EDSA logo
Edesa Biotech (EDSA)
ENZ logo
Enzo Biochem (ENZ)
UBX logo
Unity Biotechnology (UBX)
BFRG logo
Bullfrog AI Holdings (BFRG)
IXHL logo
Incannex Healthcare Limited (IXHL)
MIRA logo
MIRA Pharmaceuticals (MIRA)
BIVI logo
BioVie (BIVI)
  • What is the ticker symbol for Lipocine?
  • Does Lipocine pay dividends?
  • What sector is Lipocine in?
  • What industry is Lipocine in?
  • What country is Lipocine based in?
  • When did Lipocine go public?
  • Is Lipocine in the S&P 500?
  • Is Lipocine in the NASDAQ 100?
  • Is Lipocine in the Dow Jones?
  • When was Lipocine's last earnings report?
  • When does Lipocine report earnings?
  • Should I buy Lipocine stock now?

What is the ticker symbol for Lipocine?

The ticker symbol for Lipocine is NASDAQ:LPCN

Does Lipocine pay dividends?

No, Lipocine does not pay dividends

What sector is Lipocine in?

Lipocine is in the Healthcare sector

What industry is Lipocine in?

Lipocine is in the Biotechnology industry

What country is Lipocine based in?

Lipocine is headquartered in United States

When did Lipocine go public?

Lipocine's initial public offering (IPO) was on October 22, 2013

Is Lipocine in the S&P 500?

No, Lipocine is not included in the S&P 500 index

Is Lipocine in the NASDAQ 100?

No, Lipocine is not included in the NASDAQ 100 index

Is Lipocine in the Dow Jones?

No, Lipocine is not included in the Dow Jones index

When was Lipocine's last earnings report?

Lipocine's most recent earnings report was on Mar 13, 2025

When does Lipocine report earnings?

The next expected earnings date for Lipocine is May 9, 2025

Should I buy Lipocine stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page